OptimizeRx to Participate in Upcoming Investor Conferences [Yahoo! Finance]
OptimizeRx to Participate in Upcoming Investor Conferences
OptimizeRx Co. (NASDAQ: OPRX) had its "outperform" rating re-affirmed by analysts at William Blair.
OptimizeRx Co. (NASDAQ: OPRX) had its price target lowered by analysts at Royal Bank of Canada from $14.00 to $7.00. They now have an "outperform" rating on the stock.
OptimizeRx Co. (NASDAQ: OPRX) had its "buy" rating re-affirmed by analysts at Roth Mkm. They now have a $16.00 price target on the stock, down previously from $20.00.